ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2905

Urinary Protein:Urinary Creatinine Ratio in an Untimed Urine Specimen and Estimated Glomerular Filtration Rate Are Reliable Measures of Proteinuria and Renal Function in Patients with Lupus Nephritis

Yasuhiro Katsumata, Hirokazu Nishina, Masanori Hanaoka, Yasushi Kawaguchi, Kae Takagi, Akiko Tochimoto, Yuki Ichimura and Hisashi Yamanaka, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Lupus nephritis, proteinuria and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Renal
Disease Subcommittee of the American College of Rheumatology (ACR) Ad Hoc
Committee on Systemic Lupus Erythematosus (SLE) has recommended the urinary
protein level in a spot (untimed) urine specimen (determined as urinary
protein:urinary creatinine ratio; spot PC ratio) over a 24-hour urine protein
excretion, because it is more easily and reliably obtained. In addition, the committee
stated that renal function refers to the estimated glomerular filtration rate
(GFR) and selected the abbreviated Modification of Diet in Renal Disease (MDRD)
study equation. Accordingly, complete renal remission was defined by the ACR subcommittee
as an estimated GFR of >90 ml/minute/1.73 m2 and a urinary PC
ratio of <0.2 and inactive urinary sediment. However, recent work suggests
that the spot PC ratio may be inaccurate in the assessment of the degree of
proteinuria in lupus nephritis (LN) as compared with other forms of chronic
glomerular disease. In addition, there is no consensus as to which estimating
equation is preferred for estimated GFR. In the present study, we aimed to ensure
the reliability of spot PC ratio and estimated GFR as measures of proteinuria
and renal function in patients with LN.

Methods: A total of
46 patients with active lupus nephritis who were admitted to our hospital from
2010 through 2014 were included. All the patients met the revised ACR classification
criteria for SLE. LN was pathologically confirmed in 44 patients and renal
biopsy was not performed in the other 2 patients. Clinical and laboratory data were
retrospectively collected from the medical records and statistically analyzed.

Results: The spot
PC ration and the 24-hour urine protein excretion were highly correlated (n = 23,
Pearson’s r = 0.80). Agreement of the PC spot ratio >0.5 and the
24-hour urine protein excretion >0.5g was good (Cohen’s kappa = 0.60). The
24-hour urinary protein:urinary creatinine ratio is also highly correlated with
the 24-hour urine protein excretion (n = 32, Pearson’s r = 0.87). The estimated
GFR by the abbreviated MDRD study equation and the 24-hour urine creatinine
clearance were moderately correlated (n = 38, Pearson’s r = 0.68).

Conclusion: Our results
supported the reliability of spot PC ratio and estimated GFR by the abbreviated
MDRD study equation as measures of proteinuria and renal function in patients
with LN. Larger and prospective studies are needed to confirm and validate these
findings.


Disclosure: Y. Katsumata, None; H. Nishina, None; M. Hanaoka, None; Y. Kawaguchi, None; K. Takagi, None; A. Tochimoto, None; Y. Ichimura, None; H. Yamanaka, None.

To cite this abstract in AMA style:

Katsumata Y, Nishina H, Hanaoka M, Kawaguchi Y, Takagi K, Tochimoto A, Ichimura Y, Yamanaka H. Urinary Protein:Urinary Creatinine Ratio in an Untimed Urine Specimen and Estimated Glomerular Filtration Rate Are Reliable Measures of Proteinuria and Renal Function in Patients with Lupus Nephritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/urinary-proteinurinary-creatinine-ratio-in-an-untimed-urine-specimen-and-estimated-glomerular-filtration-rate-are-reliable-measures-of-proteinuria-and-renal-function-in-patients-with-lupus-nephritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/urinary-proteinurinary-creatinine-ratio-in-an-untimed-urine-specimen-and-estimated-glomerular-filtration-rate-are-reliable-measures-of-proteinuria-and-renal-function-in-patients-with-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology